Xavier De Cuyper introduces the Federal Agency for Medicines & Health Products (FAMHP) and the essential role it plays in Belgium’s healthcare regulatory framework since being founded in 2007. De Cuyper goes on to shed light on the organization’s several ongoing priorities which include embracing digital trends, unlocking the potential of big data, international collaboration and leadership, and closer collaboration with related industries and healthcare stakeholders.
The unavailability of medicines is, for the most part, an international problem, and thus requires international solutions
